TELA Bio, Inc. (TELA) NASDAQ
0.91
+0.01(+1.11%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.91
+0.01(+1.11%)
Currency In USD
| Market Cap | 55.4M |
| Enterprise Value | 60.21M |
| P/E Ratio | -1.31 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0.5 |
| Price/Book Ratio | -10.02 |
| Enterprise/Revenue | 0.71 |
| Enterprise/EBITDA | -1.74 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.49 |
| Operating Margin | -0.42 |
| Return On Assets | -0.57 |
| Return On Equity | -13.44 |
| Revenue | 80.28M |
| Revenue/Share | 1.41 |
| Gross Profit | 54.34M |
| EBITDA | -33.76M |
| Net Income | -38.83M |
| Diluted EPS | -0.83 |
| Total Cash | 39.54M |
| Total Cash/Share | 0.69 |
| Total Debt | 55.87M |
| Total Debt/Equity | -10.74 |
| Current Ratio | 3.61 |
| Book Value Per Share | -0.09 |
| 52-Week Change | -35.92 |
| 52-Week High | 2.2 |
| 52-Week Low | 0.5 |
| Moving Average 50 Days | 0.79 |
| Moving Average 200 Days | 1.11 |
| Average Volume | 184,180 |
| Shares Outstanding | 44.77M |
| % Held by Institutions | 57.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |